Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test
Status:
Unknown status
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
Helicobacter pylori eradication (H. pylori) rates with clarithromycin-based triple therapy
are declining, and an alternative strategy is needed urgently. The investigators sought to
compare the efficacy of pretreatment antimicrobial susceptibility-guided vs.
clarithromycin-based triple therapy vs. concomitant therapy for H. pylori eradication in a
region with high rates of multiple drug resistance.